Endometriosis among Transgender and Gender Diverse Patients Imaging Study (ETRIS).

IF 3.3 2区医学 Q1 OBSTETRICS & GYNECOLOGY

Journal of minimally invasive gynecology Pub Date : 2025-08-28 DOI:10.1016/j.jmig.2025.08.021

Maddalena Giacomozzi, Donna Ruumpol, Robert de Leeuw, Norah van Mello, Maciej Krasinski, Rufus Cartwrigh, Richard Flint, Laura Spinnewijn, Petra Verdonk, Annemiek Nap

{"title":"Endometriosis among Transgender and Gender Diverse Patients Imaging Study (ETRIS).","authors":"Maddalena Giacomozzi, Donna Ruumpol, Robert de Leeuw, Norah van Mello, Maciej Krasinski, Rufus Cartwrigh, Richard Flint, Laura Spinnewijn, Petra Verdonk, Annemiek Nap","doi":"10.1016/j.jmig.2025.08.021","DOIUrl":null,"url":null,"abstract":"Objective: to assess the prevalence of surgically confirmed endometriosis among assigned-female-at-birth (AFAB) transgender and gender diverse (TGD) individuals undergoing laparoscopic pelvic surgery.Design: retrospective multicenter cohort study from 2021 to 2024.Setting: three academic medical centers in the Netherlands and the United Kingdom.Participants: Eligible participants were AFAB TGD individuals aged ≥18 years who underwent pelvic laparoscopic surgery for any indication, including gender incongruence/dysphoria.Interventions: Data on demographics, medical history, and diagnostic imaging were analyzed using descriptive statistics. Surgical confirmation of endometriosis was the primary outcome.Results: Among 325 participants, endometriosis prevalence was 3.1% (n=10). The mean age of participants was 27.2 years and the mean body mass index (BMI) 24.9. Testosterone was predominantly used before surgery (95.4%), and among these users, 38.5% had been on testosterone for five or more years at the time of surgery. Overall, 6% of the sample reported dysmenorrhea, and among those with endometriosis, 30% experienced dysmenorrhea.Conclusion: Endometriosis was present in 3.1% of the sample. This finding differs from previous literature as it reports a lower prevalence compared to cisgender women and to other studies on TGD people. This is potentially due to prolonged use of testosterone and early initiation of gender-affirming care (GAC).","PeriodicalId":16397,"journal":{"name":"Journal of minimally invasive gynecology","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of minimally invasive gynecology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jmig.2025.08.021","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: to assess the prevalence of surgically confirmed endometriosis among assigned-female-at-birth (AFAB) transgender and gender diverse (TGD) individuals undergoing laparoscopic pelvic surgery.

Design: retrospective multicenter cohort study from 2021 to 2024.

Setting: three academic medical centers in the Netherlands and the United Kingdom.

Participants: Eligible participants were AFAB TGD individuals aged ≥18 years who underwent pelvic laparoscopic surgery for any indication, including gender incongruence/dysphoria.

Interventions: Data on demographics, medical history, and diagnostic imaging were analyzed using descriptive statistics. Surgical confirmation of endometriosis was the primary outcome.

Results: Among 325 participants, endometriosis prevalence was 3.1% (n=10). The mean age of participants was 27.2 years and the mean body mass index (BMI) 24.9. Testosterone was predominantly used before surgery (95.4%), and among these users, 38.5% had been on testosterone for five or more years at the time of surgery. Overall, 6% of the sample reported dysmenorrhea, and among those with endometriosis, 30% experienced dysmenorrhea.

Conclusion: Endometriosis was present in 3.1% of the sample. This finding differs from previous literature as it reports a lower prevalence compared to cisgender women and to other studies on TGD people. This is potentially due to prolonged use of testosterone and early initiation of gender-affirming care (GAC).

查看原文本刊更多论文

跨性别和性别差异患者子宫内膜异位症影像学研究（ETRIS）。

目的：评估经手术证实的子宫内膜异位症在接受腹腔镜盆腔手术的变性和性别多样化（TGD）患者中的患病率。设计：2021 - 2024年的回顾性多中心队列研究。环境：荷兰和英国的三个学术医疗中心。参与者：符合条件的参与者是年龄≥18岁的AFAB TGD患者，他们接受了盆腔腹腔镜手术，包括性别不一致/烦躁不安。干预措施：使用描述性统计分析人口统计学、病史和诊断成像数据。手术确认子宫内膜异位症是主要结果。结果：在325名参与者中，子宫内膜异位症患病率为3.1% （n=10）。参与者的平均年龄为27.2岁，平均身体质量指数（BMI）为24.9。手术前主要使用睾酮（95.4%），在这些使用者中，38.5%在手术时已使用睾酮5年或更长时间。总体而言，6%的样本报告痛经，在子宫内膜异位症患者中，30%经历痛经。结论：3.1%的样本存在子宫内膜异位症。这一发现与以前的文献不同，因为它报告的患病率低于顺性女性和其他关于TGD患者的研究。这可能是由于长期使用睾酮和早期开始性别确认护理（GAC）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of minimally invasive gynecology 医学-妇产科学

CiteScore

5.00

自引率

7.30%

发文量

272

审稿时长

37 days

期刊介绍： The Journal of Minimally Invasive Gynecology, formerly titled The Journal of the American Association of Gynecologic Laparoscopists, is an international clinical forum for the exchange and dissemination of ideas, findings and techniques relevant to gynecologic endoscopy and other minimally invasive procedures. The Journal, which presents research, clinical opinions and case reports from the brightest minds in gynecologic surgery, is an authoritative source informing practicing physicians of the latest, cutting-edge developments occurring in this emerging field.